MDXHNasdaqServices-Medical Laboratories
MDxHealth SA
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 3, 2026
$0.18−0.02 (-11.33%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
MDxHealth statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | MDxHealth | Industry median |
|---|---|---|
| Market Cap | $941.00K | $1.07B |
| Enterprise Value | $48.11M | $1.35B |
| PS Ratio | 0.01 | 1.63 |
Enterprise value
| Measure | MDxHealth | Industry median |
|---|---|---|
| EV / Sales | 0.45 | 1.78 |
Income (trailing twelve months)
| Measure | MDxHealth | Industry median |
|---|---|---|
| Revenue | $107.88M | $543.94M |
| Gross Profit | $69.63M | $162.51M |
| Operating Income | -$14.41M | -$1.92M |
| Pretax Income | -$35.38M | -$575.82K |
| Net Income | -$33.52M | -$1.32M |
| EBITDA | -$14.41M | -$29.24K |
| EPS (Diluted) | -$0.67 | -$0.02 |
Margins
| Measure | MDxHealth | Industry median |
|---|---|---|
| Gross Margin | 64.5% | 32.7% |
| Operating Margin | -13.4% | -4.46% |
| Pretax Margin | -32.8% | 1.47% |
| Profit Margin | -31.1% | -3.18% |
| EBITDA Margin | -13.4% | 2.41% |
| FCF Margin | -3.10% | 3.11% |
Returns
| Measure | MDxHealth | Industry median |
|---|---|---|
| Return on Assets (ROA) | -22.0% | -3.06% |
| Return on Capital Employed (ROCE) | -14.6% | -2.29% |
Growth
| Measure | MDxHealth | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 19.8% | 7.11% |
| Revenue Growth (3Y CAGR) | 42.8% | 10.9% |
| Revenue Growth (5Y CAGR) | 42.3% | 13.2% |
Balance sheet
| Measure | MDxHealth | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $29.03M | $47.58M |
| Total Debt | $76.20M | $180.01M |
| Net Cash (Debt) | -$47.17M | $217.65K |
| Net Cash Per Share | -$0.92 | $0.01 |
| Working Capital | $3.88M | $29.77M |
Financial position
| Measure | MDxHealth | Industry median |
|---|---|---|
| Current Ratio | 1.08 | 1.41 |
| Quick Ratio | 0.88 | 0.97 |
| Interest Coverage | -0.63 | -0.90 |
Cash flow (trailing twelve months)
| Measure | MDxHealth | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.19M | $1.28M |
| Capital Expenditures | -$1.16M | -$16.47M |
| Free Cash Flow | -$3.35M | $23.23M |
| FCF Per Share | -$0.07 | $0.37 |
Efficiency
| Measure | MDxHealth | Industry median |
|---|---|---|
| Asset Turnover | 0.71 | 0.83 |
| Inventory Turnover | 7.21 | 11.36 |
| Revenue Per Employee | $296.36K | $218.24K |
| Profits Per Employee | -$92.09K | -$5.96K |
| Employee Count | 364 | 897 |
Dividends and yields
| Measure | MDxHealth | Industry median |
|---|---|---|
| Earnings Yield | -3562.1% | -1.25% |
| FCF Yield | -355.6% | 1.43% |
Shares
| Measure | MDxHealth | Industry median |
|---|---|---|
| Shares Outstanding | 51,364,500 | 58,609,450 |
| Shares Change (YoY) | 52.0% | 2.64% |
Taxes
| Measure | MDxHealth | Industry median |
|---|---|---|
| Income Tax | -$1.86M | $671.50K |
Scores
| Measure | MDxHealth | Industry median |
|---|---|---|
| Altman Z-Score | -3.37 | 1.98 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from MDxHealth's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.